.2012 .synthesis of the literature. J Gastrointest Surg, : .
.1984 .. Am J Med, 77(1) : 147-50.
Chen H,Sippel RS,Pacak K. .2010 .The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma & Medullary Thyroid Cancer. Pancreas, 39(6) : 775-783.
Frantzen C,Klasson TD,Links TP,Pagon RA,Adam MP,Ardinger HH . .. GeneReviews®, 6 : 1993-2016.
Siegel RL,Miller KD,Jemal A .2016 .. , 66(1) : 7-30.
Zuber SM,Kantorovich V,Pacak K. .2011 .Hypertension in Pheochromocytoma: Characteristics and Treatment. Endocrinology and metabolism clinics of North America. , 40(2) : 295-311.
Ata-ur-Rehman R,Ashraf S,Rahim J,Hussain N,Jamil MN,Tahir MM .2015 .Clinical presentation of renal cell carcinoma. J Ayub Med Coll Abbottabad, 27(2) : 326-8.
Puri S,Cano DA,Hebrok M. .2009 .A role for von HippelLindau protein in pancreatic beta-cell function. Diabetes, 58(2) : 433-41.
Cantley J,Grey ST,Maxwell PH,Withers DJ .2010 .The hypoxia response pathway and β-cell function. Diabetes Obes Metab, 12(Suppl 2) : 159-67.
Sakagami H,Makino Y,Mizumoto K,Isoe T,Takeda Y,Watanabe J .2014 .Loss of HIF-1α impairs GLUT4 translocation and glucose uptake by the skeletal muscle cells. Am J Physiol Endocrinol Metab, 306(9) : E1065-76.
Van Belle TL,Coppieters KT .2011 .Von Herrath MG. Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies. Physiol Rev, 91(1) : 79-118.
Sheth MN,Nations SP,Wolfe GI,Trivedi JR .2005 .Von hippel-lindau disease associated with thymoma and myasthenia gravis. J Clin Neuromuscul Dis, 7(2) : 59-61.
Tenner S,Roston A,Lichtenstein D,Sica G,Carr-Locke D,Banks PA .1995 .Von Hippel-Lindau disease complicated by acute pancreatitis and Evan's syndrome. Int J Pancreatol, 18(3) : 271-5.